Research programme: anti-CD44v6 peptides - amcureAlternative Names: AM-001 - amcure
Latest Information Update: 03 Nov 2016
At a glance
- Originator amcure
- Class Peptides
- Mechanism of Action CD44 antigen inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pancreatic cancer; Solid tumours
Most Recent Events
- 26 Apr 2012 Preclinical trials in Pancreatic cancer (Late-stage disease, Metastatic disease) in Germany (Parenteral)
- 26 Apr 2012 Preclinical trials in Solid tumours (Late-stage disease, Metastatic disease) in Germany (Parenteral)